Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Clinical Operations.Register Now
The Clinical Operations Strategy Meeting are for qualified end-users. These include senior executives of Clinical Operations (from a mix of emerging to large Pharma, Biopharma and Biotech players) as well as thought leaders from Academia and Regulatory Authorities.
Thought leaders who will benefit from attending include CxOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
Clinical Operations, Data Sciences, Clinical Outsourcing, Patient Recruitment, Site Selection, RBM, eTMF, Safety Data Management, Clinical Trial Management, Data Acquisition Technology and Integrations, Clinical, Pharmacology Scientific Operations, Clinical Informatics and Innovation.
Those who do not qualify for VIP passes, including vendors offering: Products, Services, Exchanges, Consultancy and CRO/CDMO solutions who can apply here for more information.
Clinical Development Program Director, Ipsen
Prior to joining Ipsen, She assumed demanding responsibilities within Servier as Alliance Management Project Director, overseeing two partnerships (with Pfizer and Cellectis) in immuno-oncology.
Prior to that, She has been working 15 years within Clinical Operations. I got a broad experience on the management of international clinical trials in partnerships with internal and external partners (academic, local, middle and big size CROs) through a position as Director of International Clinical Study Management. Through these different positions she developed a strong leadership, organisational skills and positive team spirit looking to accomplish challenging missions.
Head of Statistics, Mitsubishi Tanabe
Clinical Operations Strategy Meeting Europe 2016,
Bayerstrasse 12 80335 Munich,